Peter DeMuth

Insider Reports History

Location
C/O Elicio Therapeutics, Inc., 451 D Street, 5 Th Floor, Suite 501, Boston, MA
Signature
/s/ Peter DeMuth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter DeMuth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Elicio Therapeutics, Inc. Chief Scientific Officer Common Stock 381 $1.68K $4.41 Dec 16, 2024 Direct
Elicio Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 44.4K Feb 3, 2025 Direct

Insider Reports Filed by Peter DeMuth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELTX Elicio Therapeutics, Inc. Feb 3, 2025 1 $0 4 Feb 4, 2025 Chief Scientific Officer
ELTX Elicio Therapeutics, Inc. Dec 16, 2024 2 $1.68K 4 Dec 18, 2024 Chief Scientific Officer
ELTX Elicio Therapeutics, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Chief Scientific Officer
ELTX Elicio Therapeutics, Inc. Feb 1, 2024 2 $0 4 Feb 5, 2024 Chief Scientific Officer
ELTX Elicio Therapeutics, Inc. Jun 1, 2023 0 $0 3 Jun 7, 2023 Chief Scientific Officer